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Chromatin remodeller SMARCA4
recruits topoisomerase 1 and suppresses
transcription-associated genomic instability
Afzal Husain1, Nasim A. Begum1, Takako Taniguchi2, Hisaaki Taniguchi2, Maki Kobayashi1 & Tasuku Honjo1
Topoisomerase 1, an enzyme that relieves superhelical tension, is implicated in transcription-
associated mutagenesis and genome instability-associated with neurodegenerative
diseases as well as activation-induced cytidine deaminase. From proteomic analysis of
TOP1-associated proteins, we identify SMARCA4, an ATP-dependent chromatin remodeller;
FACT, a histone chaperone; and H3K4me3, a transcriptionally active chromatin marker.
Here we show that SMARCA4 knockdown in a B-cell line decreases TOP1 recruitment to
chromatin, and leads to increases in Igh/c-Myc chromosomal translocations, variable and
switch region mutations and negative superhelicity, all of which are also observed in response
to TOP1 knockdown. In contrast, FACT knockdown inhibits association of TOP1 with
H3K4me3, and severely reduces DNA cleavage and Igh/c-Myc translocations, without
signiﬁcant effect on TOP1 recruitment to chromatin. We thus propose that SMARCA4 is
involved in the TOP1 recruitment to general chromatin, whereas FACT is required for TOP1
binding to H3K4me3 at non-B DNA containing chromatin for the site-speciﬁc cleavage.
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opoisomerase 1 (TOP1) is an enzyme that relieves the
superhelical tension generated when the transcription
machinery travels along DNA. Normally, TOP1 nicks
DNA, forms a transient covalent bond between its tyrosine
residue and the 30 phosphate of the nicked DNA, rotates DNA
around the helix, and then re-ligates the cleaved ends to release
negative or positive supercoils that accumulate behind or in front,
respectively, of elongating RNA polymerase II (Pol II)1,2. High
levels of transcription can lead to the accumulation of negative
supercoils behind RNA pol II and facilitate the formation of non-
B DNA structures, particularly at repeat-containing sequences.
These changes in DNA structure are likely due to insufﬁcient
levels of TOP1. In fact, TOP1 reduction by small interfering
RNA (siRNA) induces high levels of genomic instability2–4. The
accumulated non-B DNA structures may promote genomic
instability by posing steric hindrance in the rotation or
re-ligation of cleaved ends following DNA nicking by TOP1,
resulting in irreversible DNA cleavage2–10.
TOP1 was recently shown to be responsible for 2–5-bp
deletions that occur during transcription-associated mutagenesis,
and the triplet-repeat instability associated with triplet diseases
such as Huntington’s disease11–14. In addition, defects in
DNA damage response factors involved in the processing of
TOP1-DNA lesions, such as ataxia telangiectasia mutated,
TDP1 (tyrosyl-DNA phosphodiesterase 1), Aprataxin and
PNKP (polynucleotide kinase phosphatase), are implicated in
neurodegenerative genome instability syndromes such as ataxia
telangiectasia, spinocerebellar ataxia with axonal neuropathy 1,
ataxia with oculomotor apraxia type 1, and microcephaly with
early-onset, intractable seizures and developmental delay,
respectively15–18. It is important to stress that these genome
instabilities in the nerve cells do not depend on replication, but
depend on transcription in which TOP1 plays a critical role.
Another enzyme associated with genomic stress is activation-
induced cytidine deaminase (AID), which is normally responsible
for the DNA cleavage in the switch (S) and variable (V) regions
of the immunoglobulin (Ig) locus, which initiates class switch
recombination (CSR) and somatic hypermutation (SHM),
respectively19–21. Aberrant expression of AID induces a high
frequency of mutations and chromosomal translocations in B as
well as non-B cells that eventually leads to increased tumour
formation22. It has also been shown that the activation of AID
reduces TOP1 protein expression23, while the artiﬁcial reduction
of TOP1 by siRNA augments AID-induced DNA cleavage, SHM
and CSR23,24. Furthermore, the reduced expression of TOP1 in
Top1 heterozygous knockout mice leads to a dramatic increase in
the frequency of SHM in Peyer’s patch B cells24. These ﬁndings
indicate that reduction in the TOP1 protein level enhances the
DNA cleavage that augments SHM or CSR. However, trapping
the TOP1-DNA intermediates by camptothecin inhibits both
CSR and SHM, suggesting that the appropriate processing
of TOP1-DNA lesions is also required for SHM and CSR.
Taken together, these ﬁndings suggest that AID-dependent
chromosomal translocations may serve as a model to study
TOP1-mediated genomic instability.
Preferred targets of TOP1-mediated genomic instability are
highly transcribed and enriched in repetitive sequences11–13.
Notably, the targeted loci of AID-induced DNA cleavage also
share similar properties25–28. Ig gene targeting by AID has been
proposed to depend not only on the cis marking by secondary
DNA structures such as non-B DNAs, produced by excessive
transcription at repeat-containing AID targets, but also on
trans marking by a variety of chromatin factors, including
histone H3 tri-methyl at Lys4 (H3K4me3)23,26,29. Consistent
with this proposal, transcription elongation factors, such as
FACT (a heterodimeric complex composed of SSRP1 and
SPT16/SUPT16H), SPT6/SUPT6H, SPT5/SUPT5H and H3K4me3-
methyltransferases, which are required for the maintenance of
H3K4me3, are essential for AID-induced genetic alterations29–32.
Furthermore, non-canonical AID targets such as MYC, MALAT1
and SNHG3, identiﬁed in a genome-wide study, are highly
transcribed, ﬂanked by repetitive sequences, and enriched with
H3K4me3 as well as FACT25,26,32,33.
There is evidence that a large number of chromatin-modifying
proteins are also involved in the maintenance of genomic
stability. Among these, proteins found in the SWI/SNF chromatin
remodelling complexes, which are also referred to as BAF
(BRG1-associated factor) complexes, are frequently mutated in
human cancers, suggesting that the inactivation of these
proteins may induce the genomic instability that contributes to
tumorigenesis34,35. However, the mechanisms by which BAF
complex inactivation cause genomic instability are not well
understood. The BAF complexes are highly polymorphic
assemblies containing ATPase SMARCA4 (also called BRG1),
which utilizes ATP hydrolysis to modulate non-covalent
chromatin structural changes by destabilizing, removing, sliding
and restructuring nucleosomes36,37.
To understand the molecular mechanisms involved in
TOP1-mediated genomic instability, we sought to identify
proteins responsible for TOP1 recruitment to chromatin. We
performed TOP1 co-immunoprecipitations (co-IPs) followed by
protein identiﬁcation by mass spectrometry (MS) to identify
proteins that associate with TOP1. Among the co-precipitated
proteins, we found that SMARCA4 is involved in the recruitment
of TOP1 to chromatin. Some of the recruited TOP1 interacts with
the FACT that accumulates at non-B DNA containing chromatin,
and forms a complex with the chromatin mark H3K4me3.
Subsequently, the TOP1 complex induces breaks at non-B DNA
formed at the repeat containing DNA sequences. Our ﬁndings
indicate that SMARCA4 and FACT are involved in the
regulation of TOP1-dependent genomic instability associated
with transcription.
Results
Proteomic analysis of TOP1-associated proteins. We carried
out co-immunoprecipitation experiments using a transfectant
of the TOP1-deﬁcient mouse B-lymphocytic leukemia
cell-line P388/CPT45, that stably expresses GFP-tagged human
TOP1 (GFP-TOP1) and the estrogen-binding domain (ER)-AID
(AIDER) fusion protein24. Immunoprecipitations (IPs) were
performed using the GFP-Trap system, followed by
protein identiﬁcation with one-dimensional SDS–PAGE (SDS
polyacrylamide gel electrophoresis) separation and mass
spectrometry.
We used dithiobis-succinimidyl propionate (DSP), a cell-
permeable and thiol-reversible chemical crosslinker, to identify
labile but functionally relevant TOP1-interacting proteins. To
generate a real-time snapshot of the TOP1-protein interactome
in vivo, AID-activated P388/CPT45-GFP-TOP1 transfectants
were treated with DSP (0.6mM) for 30min, followed by IP
(DSP-IP) and MS-identiﬁcation of the immunoprecipitated
(IPed) proteins (Fig. 1a–d). Under these conditions, TOP1 was
efﬁciently crosslinked to its interacting partners, and the IPed
fraction contained only the crosslinked form of TOP1, which was
thiol-reversible (Supplementary Fig. 1a,b). To overcome the
shortcomings of DSP-IP, such as nonspeciﬁc protein trapping, we
also performed IP without crosslinking (native-IP), although
proteins with labile TOP1 interactions may be lost with this
method (Fig. 1a–d; Supplementary Fig. 1c). We postulated that
molecules commonly trapped by both methods may be a more
reliable representation of the TOP1 interactome than molecules
identiﬁed by only one method.
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Figure 1 | Proteome-wide identiﬁcation of TOP1-associated proteins. (a) Representative silver-stained gels of protein fractions obtained from
GFP-TOP1 IPs performed under native (Native-IP) or DSP-cross-linked conditions (DSP-IP). Immunoprecipitations were performed with GFP-Trap_A
using nuclear extracts prepared from 2 108 DSP treated or untreated P388/CPT45 cells expressing either GFP (P388/CPT45-GFP) or GFP-TOP1
(P388/CPT45-GFP-TOP1) as described in the ‘Methods’. The IPed proteins were electrophoresed on SDS–PAGE gel (4–20% acrylamide gel) and visualized
with SilverQuest Silver Staining Kit (Invitrogen). Open and closed triangles represent the protein bands corresponding to GFP-TOP1 or GFP alone,
respectively. For MS analysis, IPed proteins were processed as described in the ‘Methods’. (b) Venn diagram representing LC-MS/MS identiﬁed
TOP1-associated proteins obtained by DSP- or native-IP. The number of proteins identiﬁed by each method is shown in parentheses. The complete list of
MS identiﬁed proteins is shown in Supplementary Tables 1 and 2. (c) Functional classiﬁcation of TOP1-associated proteins. The number of common proteins
identiﬁed by both methods in the various groups is shown in parentheses. (d) Physical and functional interactions among the TOP1-associated proteins
based on information obtained from the STRING 9.1 database (http://string-db.org). Proteins identiﬁed by both methods are shown in ellipses, whereas
those identiﬁed by either DSP-IP or native-IP are shown in rectangles or hexagons, respectively. Red coloured edges represent known TOP1 associations
identiﬁed in the STRING database. Proteins that are not connected with rest of the network showed no evidence of association with TOP1 or the other
network proteins in the STRING database. The colour of each node represents the functional class shown on the left. (e) Fold enrichment of the common
proteins identiﬁed by GFP-TOP1 IP compared with their levels in GFP IPs from control cells. The fold enrichments of all the proteins identiﬁed by each
method are shown in Supplementary Tables 1 and 2. DSP, dithiobis-succinimidyl propionate.
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The MS analysis of proteins obtained by DSP- and native-IP
from GFP-TOP1-expressing cells led to the identiﬁcations of 88
and 63 proteins, respectively (Supplementary Tables 1 and 2).
Among the co-IPed proteins, 65 proteins were identiﬁed by
DSP-IP alone, 40 proteins were identiﬁed by native-IP alone,
and 23 proteins were identiﬁed by both methods (Fig. 1b).
Theoretically, all the proteins that were identiﬁed by native-IP
should be picked up by DSP-IP due to their further stabilization
by crosslinking. However, despite stabilization of the labile
interactions, crosslinking negatively affects the extraction of many
protein complexes likely due to their crosslinking with other
non-soluble proteins such as those in the nuclear matrix, and thus
limits their successful IP and identiﬁcation by MS. The functional
classiﬁcation of the 128 unique TOP1-associated proteins
suggests that TOP1 may be a central component of a large
protein interaction network associated with transcription, DNA
repair and other chromatin-related functions (Fig. 1c).
To further elucidate the functional relationships among the
TOP1-associated proteins, we mapped them using the STRING
database, a knowledge base of protein associations, and visualized
the interactions by Cytoscape 3.2 (refs 38,39). As shown in
Fig. 1d, 113 (88%) of these proteins were connected by a
functional network, suggesting that the TOP1-associated proteins
were functionally interrelated. Notably, only 28 of the 113
proteins in this network were previously known to associate with
TOP1; these included SRSF1, NCL, ELAVL1, FBL, NONO, SFPQ,
TCOF1, PARP1 and BTBD1. One of the major pathways
implicated in the repair of DNA damage induced by
TOP1-DNA adducts requires proteolysis of TOP1 by proteasome,
excision by TDP1, followed by repair that requires the action of
XRCC1 complex proteins such as PNKP, PARP1, LIGIII and
POLB. Interestingly, all of these were identiﬁed in our proteomic
studies (Supplementary Tables 1 and 2)40. These results indicate
that the experimental strategies described here identiﬁed both
known and novel TOP1-associated proteins.
TOP1-associated proteins are required for efﬁcient CSR. We
focused on the proteins identiﬁed by both methods, which
included histone chaperones and transcription elongation factors
(SSRP1, SPT16, SPT6), chromatin remodelling complex proteins
(SMARCA4, CHD4 and RBBP7), DNA repair proteins (PARP1
and XRCC1) and proteins involved in splicing and ribosome
biogenesis (Fig. 1e). In addition to SMARCA4, other components
of the BAF complex such as SMARCC1, ARID1A and ACTL6A
were also identiﬁed by DSP-IP (Supplementary Table 1). To
investigate the functional relevance of these proteins in TOP1
recruitment, we performed siRNA-mediated knockdown (KD) of
these proteins in CH12F3-2A cells, and assessed the effects on
IgM to IgA switching in response to stimulation with CD40L, IL4,
and TGFb (CIT) (Fig. 2a). We were particularly interested in the
proteins involved in chromatin modiﬁcation because of their
likely involvement in recruiting TOP1 to chromatin. The KD of
the transcription elongation-associated histone chaperones,
SPT6 and FACT (SSRP1 and SPT16) strongly reduced CSR as
previously shown29,30,41. The KD of the chromatin remodelling
proteins SMARCA4, CHD4 and RBBP7 led to 70%, 50% and
30% reductions in CSR, respectively (Fig. 2a; Supplementary
Fig. 2a–c). Thus, we concentrated on the role of SMARCA4 and
FACT in TOP1 recruitment, as SPT6 is known to directly regulate
AID expression.
We conﬁrmed that both SMARCA4 and FACT (SSRP1 and
SPT16 subunits) were speciﬁcally IPed from GFP-TOP1-
expressing cells, but not from control cells expressing GFP alone
(Fig. 2b; Supplementary Fig. 1d–f). In addition, we conﬁrmed the
interaction of TOP1 with other transcription-associated proteins,
such as RNA pol II and SPT5, a subunit of the DSIF (DRB
sensitivity inducing factor) complex, which were also found in the
proteomic analysis, albeit with lower enrichment. These results
not only validated the proteomic data, but also suggested that
recruitment of TOP1 may be transcription-dependent. Consistent
with this notion, treating CH12F3-2A cells with the transcription
inhibitors DRB (5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole,
25 mM for 24 h) or ActD (actinomycin D, 2 mM for 4 h)
dramatically decreased the TOP1-ChIP (chromatin immuno-
precipitation) signal at the Igh locus (Supplementary Fig. 3).
To gain insight into the role of epigenetic marking on TOP1
recruitment, the TOP1-co-IPed proteins were analysed for the
presence of several histone post-translational modiﬁcations
(PTMs). We found that TOP1-associated chromatin was highly
enriched in H3K4me3 as compared with other tested histone-
PTMs (H3-acetyl, H4-acetyl, H3S10P, H3S28P, H3K27me3 and
H3K9me3; Fig. 2c). These data suggest that TOP1 may
preferentially bind to H3K4me3, and be likely enriched in the
H3K4me3-modiﬁed genomic regions.
SMARCA4 depletion augments AID-induced genomic instability.
The KD of SMARCA4 in CH12F3-2A cells with three individual
siRNAs or their pool inhibited IgA switching without causing
signiﬁcant cell death (Supplementary Figs 2a–c and 4a–d), and
reduced the expression of a-germline transcripts (GLTs)
(Supplementary Fig. 2d). Drastic reduction of SMARCA4 by
siRNA had a very limited effect on cell proliferation,
suggesting that CSR inhibition upon SMARCA4 KD is largely due
to the inhibition of aGLT expression (Supplementary Fig. 2d,e).
To further conﬁrm this possibility, we performed the CSR assay
using an artiﬁcial switch substrate in AIDER expressing NIH3T3
cells42. SMARCA4 KD in these cells reduced neither CSR nor the
expression of Sm or Sa transcripts (Pre-Tr1 and Pre-Tr2) from the
artiﬁcial promoters (Supplementary Fig. 2f–h). The data further
conﬁrmed that CSR defect upon SMARCA4 KD in CH12F32-A
cells is due to the inhibition of aGLT expression.
We next analysed the role of SMARCA4 in SHM. To
determine the effect of SMARCA4 KD on V region SHM, we
used AID-knockout BL2 cells (human Burkitt’s lymphoma line)
expressing AIDER (BL2-AID /AIDER)43,44. After transfection
with siRNA-targeting human SMARCA4, the cells were treated
with 4-hydroxytamoxifen (OHT) from days 1 to 4 to activate
AID, and the 426-bp rearranged VH4–39-JH5 region was
sequenced (Fig. 3a). Transfection of SMARCA4 siRNA
sufﬁciently suppressed SMARCA4 protein expression, as
compared with the effect of control non-targeting siRNA with a
similar GC content (Fig. 3b). The KD of SMARCA4 increased the
SHM frequency in the V(D)J region induced by AIDER activation
(Fig. 3c; Supplementary Tables 3 and 4).
As the enhancement of SHM by SMARCA4 KD is reminiscent
of that induced by TOP1 depletion, we speculated that
SMARCA4 depletion in BL2 cells may affect TOP1 function,
which led to enhanced DNA cleavage and SHM. To test this
possibility, we analysed the effect of SMARCA4 KD on SHM in
the Sm region of the TOP1-deﬁcient P388/CPT45 cells expressing
either GFP (P388/CPT45-GFP) or GFP-TOP1 (P388/CPT45-
GFP-TOP1; Fig. 3d–g; Supplementary Tables 5 and 6).
Introducing SMARCA4 siRNA into these cells efﬁciently reduced
the SMARCA4 protein expression (Fig. 3f). As reported
previously24, expression of GFP-TOP1 in the TOP1-deﬁcient
P388/CPT45 cells resulted in a clear reduction in SHM frequency
(Fig. 3g). Notably, SMARCA4 depletion rescued the decrease in
SHM frequency in the P388/CPT45-GFP-TOP1 cells, suggesting
that SMARCA4 reduction counteracts TOP1 overexpression.
Interestingly, SHM augmentation by SMARCA4 KD was not
observed in TOP1-deﬁcient P388/CPT45-GFP cells, conﬁrming
that SMARCA4 depletion and TOP1 deﬁciency are functionally
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related. Since increased mutations may represent increments in
the double-stranded breaks (DSBs), we analysed the effect of
SMARCA4 depletion on the H2AX phosphorylation. Indeed,
depletion of SMARCA4 in CH12F3-2A cells resulted in the
increased formation of AID-induced gH2AX foci in the Sm region
(Fig. 3h).
As TOP1 reduction is known to cause genomic instability,
we assessed the effect of SMARCA4 KD on the chromosomal
translocations involving the c-Myc oncogene and Igh locus, a
hallmark of various B-cell malignancies. The products of long-
range PCR ampliﬁcation of the translocated genomic DNA using
Igh- and c-Myc-speciﬁc primers were detected by Southern
blotting with Myc probes (Fig. 4a). Depletion of either SMARCA4
or TOP1 with siRNA in CH12F3-2A cells led to dramatically
increased translocation frequencies (Fig. 4b–d); however, the
frequency of translocations upon TOP1 KD was higher than that
observed upon SMARCA4 KD. This conclusion is further
conﬁrmed by the KD of SMARCA4 with the pool of three
SMARCA4 siRNAs (Supplementary Fig. 4f). In addition,
although SMARCA4 KD augmented the chromosomal transloca-
tion frequency in TOP1-expressing cells, it had no effect on
chromosomal translocation in CH12F3-2A cells expressing
microRNA directed against Top1 mRNA (Fig. 4e–g). To exclude
the possibility that absence of the chromosomal translocation
increase by SMARCA4 KD in TOP1-depleted cells is not due to
saturation of the assay sensitivity, we performed the translocation
assay using lesser amount of genomic DNA (300 ng instead of
750 ng per PCR reaction). Even under this unsaturated assay
conditions, we failed to see additive increments in the Igh/c-Myc
translocations (Supplementary Fig. 5). These results conﬁrmed
that the effect of SMARCA4 KD on chromosomal translocations
was dependent on the presence of TOP1. In addition,
we also showed that complementation of siRNA-mediated
KD of SMARCA4 by the co-transfection of plasmid expressing
siRNA-resistant WT-SMARCA4 abolished the increments in
Igh/c-Myc translocations (Supplementary Fig. 6).
FACT is essential for AID-induced genomic instability.
We next investigated the role of FACT, another prominent
component of the TOP1 complex, and found that FACT
depletion in CH12F3-2A cells caused a dramatic reduction
in the Igh/c-Myc chromosomal translocations induced by AID
expression (Fig. 5a–c,e,g). The results suggest that unlike TOP1
and SMARCA4, FACT facilitates AID-induced genomic
instability. To further conﬁrm this possibility, we assayed the
AID-induced Igh/c-Myc chromosomal translocations upon
simultaneous KD of TOP1 and FACT in CH12F3-2A cells.
Surprisingly, FACT KD abolished the TOP1 depletion-mediated
augmentation of Igh/c-Myc chromosomal translocations
(compare Fig. 4c versus Fig. 5d,e). When we measured formation
of DSBs using ligation-mediated PCR, FACT depletion severely
reduced the formation of AID-induced DSBs, which is consistent
with our previous studies29 (Fig. 5f). These data suggest that
FACT expression is essential for DNA cleavage at Ig andMyc loci,
even in TOP1-deﬁcient cells. Thus, FACT and SMARCA4 play
distinct roles in AID-induced genomic instability.
SMARCA4 depletion reduces TOP1 recruitment to chromatin.
Since TOP1 is required for augmentation of SHM and chromo-
somal translocations by SMARCA4 depletion, we speculated that
SMARCA4 is involved in TOP1 deposition at the Igh locus, and
thus we performed TOP1-ChIP using CH12F3-2A cells following
transfection with SMARCA4 siRNA. Indeed, SMARCA4
depletion reduced deposition of TOP1 in the Sm region, con-
ﬁrming that TOP1 association with SMARCA4 is functionally
relevant and required for efﬁcient TOP1 deposition at the Igh
locus (Fig. 6a). The reduction in the recruitment of TOP1 upon
SMARCA4 KD was further conﬁrmed by TOP1-ChIP analysis
upon SMARCA4 KD by the pool of three SMARCA4 siRNAs
(Supplementary Fig. 4e). The reduction in association of TOP1
with chromatin causes the accumulation of negative supercoils
behind elongating RNA Pol II, resulting in the formation of
non-B DNA structures as well as single-stranded patches of
DNA4,9,10,23,45. To evaluate the relative frequencies of negative
superhelicity, we used biotin-trimethylpsoralen (bTMP), which
preferentially intercalates into under-wound DNA, followed by
ultraviolet-crosslinking, streptavidin-based IP of the crosslinked










































































































Figure 2 | TOP1-associated proteins are required for efﬁcient CSR. (a) Effect of siRNA-mediated KD of histone chaperones and chromatin remodellers
on IgM to IgA switching in CH12F3-2A cells. After electroporation of the indicated siRNAs, cells were cultured for 24 h, and then stimulated by CIT for
another 24 h before FACS analysis. Data are presented as % IgA switching relative to the IgA switching in cells transfected with control siRNA (siCONT)
with similar GC content. The data represents the mean of the three independent experiments with standard deviations. Statistical signiﬁcance as evaluated
by Student’s t-test is shown. (b) Conﬁrmation of association of TOP1 with FACT, SMARCA4 and other transcription-associated proteins. The nuclei from
2 108 P388/CPT45 transfectants expressing either GFP (P388/CPT45-GFP) or GFP-TOP1 (P388/CPT45-GFP-TOP1) were IPed with GFP-Trap_A as
described for native-IP in the ‘Methods’, and 5–10% of the IPed proteins were electrophoresed on 4–20% SDS–PAGE gradient gel, followed by western blot
with indicated antibodies. (c) Association of TOP1 with H3K4me3 and other histone PTMs. Immunoprecipitated proteins obtained in b were
immunoblotted to test for the presence of the indicated histone-PTMs using their speciﬁc antibodies. The position of molecular weight markers is
shown on the left of each western blot image.
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(qPCR; Supplementary Fig. 7a). The ultraviolet-dependent
incorporation of bTMP into genomic DNA was conﬁrmed by a
dot blot (Supplementary Fig. 7b). Using this method, we found
that more bTMP was incorporated into the Sm region of
TOP1-deﬁcient P388 cells (P388/CPT45-GFP), compared with
cells expressing exogenous TOP1 (P388/CPT45-GFP-TOP1),
indicating that S-region DNA is more negatively supercoiled
in TOP1-deﬁcient cells (Fig. 6b). Similarly, SMARCA4 KD in
CH12F3-2A cells also led to the enhanced accumulation of
negative supercoils (Fig. 6c). These results further conﬁrm the
involvement of SMARCA4 in recruitment of TOP1, which
suppresses the formation of non-B DNA structures by correcting
uneven distribution of superhelix.
Next, we analyse the effect of SMARCA4 depletion on TOP1
recruitment and negative supercoiling at non-Igh AID target loci
identiﬁed by whole-genome sequencing46–48. Among these; Pim1,
Cd83, Cd79b, Ly6e, IL4ra and Myc are efﬁciently expressed in









































































































































































































Figure 3 | SMARCA4 depletion augments SHM in a TOP1-dependent manner. (a) Top: experimental design for SHM analysis of the V region in
BL2-AID/AIDER cells. Bottom: schematic representation of recombined V(D)J region of BL2-AID/AIDER cells. The region analysed for SHM is
underlined. (b) Conﬁrmation of siRNA-mediated KD of SMARCA4 in BL2-AID/AIDER cells. Expression of AIDER is also shown. Tubulin is used as
loading control. (c) Mutation frequency in the V region after 3 days of AIDER activation by OHT treatment. Details of the mutation analysis are shown in
Supplementary Tables 3 and 4. (d) Left: schematic illustration of the experimental design for SHM analysis of the Sm region in P388/CPT45 cells. Right:
schematic representation of Sm region of P388/CPT45 cells. The 50 Sm region analysed for SHM is underlined. (e) Expression of GFP or GFP-TOP1, and
AIDER in P388/CPT45 cells expressing either GFP (P388/CPT45-GFP) or GFP-TOP1 (P388/CPT45-GFP-TOP1) is analysed by western blotting with
indicated antibodies. (f) Conﬁrmation of siRNA-mediated KD of SMARCA4 in P388/CPT45 cells by western blotting with indicated antibodies. Expression
of b-actin is shown as loading control. (g) Mutation frequency in the Sm region after 3 days of AIDER activation by OHT. Details of the mutation analysis are
shown in Supplementary Tables 5 and 6. (h) Left: Schematic representation of the gH2AX-ChIP assay using CH12F3-2A cells (top), and conﬁrmation of
SMARCA4 KD by western blot with anti-SMARCA4 antibody. Expression of tubulin is shown as a loading control. Right: gH2AX-ChIP signal in Sm region is
represented as the fraction of immunoprecipitated DNA (%IP) normalized to the total amount of DNA used for immunoprecipitation. gH2AX-ChIP signal at
b-actin (Actb), an AID non-targeted gene, is used as a negative control. The data represents the mean of the three independent experiments with standard
deviations. Statistical signiﬁcance as evaluated by Fisher’s exact test (c,g) or Student’s t-test (h) is shown. The position of molecular weight markers is
shown on the left of each western blot image. AIDER, AID fused with the hormone-binding domain of the estrogen receptor (ER); NS, not signiﬁcant;
OHT, 4-hydroxytamoxifen; SHM, somatic hypermutation.
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SMARCA4 by siRNAs resulted in the decrements in the TOP1
recruitment to these loci. Consistently, we found that SMARCA4
depletion leads to the increment in the incorporation of bTMP,
a marker for an increment in negative supercoils (Fig. 7b).
Interestingly, neither TOP1 recruitment nor bTMP incorporation
was observed at a non-transcribed gene (Tcrd), indicating a
requirement of transcription for both TOP1 recruitment and
accumulation of negative supercoils. Together, these data show
that SMARCA4 is a general recruiter of TOP1, and required to
maintain B- DNA structures.
As depletion of SMARCA4 caused reduction in TOP1
recruitment to non-Igh AID target loci, we analysed the
formation DSBs at these loci using gH2AX-ChIP assays. The
depletion of SMARCA4 resulted in the increased DSBs at these
loci (Supplementary Fig. 8a,b). Next, we investigated the H2AX
phosphorylation by ﬂow cytometry to assay the effect of
SMARCA4 depletion on the global DSB formation. As shown
in Supplementary Fig. 8c,d, we could not see large changes
in the gH2AX level upon SMARCA4 depletion both in































































































































































































Figure 4 | SMARCA4 depletion augments chromosomal translocations in a TOP1-dependent manner. (a) Top: schematic illustration of experimental
design for translocation assay in CH12F3-2A cells. Bottom: PCR ampliﬁcation scheme to detect Igh/c-Myc chromosomal translocations. Triangles represent
the positions of primers used to amplify the rearranged regions. The position of the Myc probe used in the Southern blot hybridization is shown as a
horizontal black bar. (b) Conﬁrmation of SMARCA4 or TOP1 KD by their respective siRNAs in CH12F3-2A cells used in the translocation assay shown in c
and d. Expression of tubulin is shown as loading control. (c) Southern blot analysis of PCR-ampliﬁed fragments with Myc-speciﬁc probe. The CH12F3-2A
cells were transfected with the indicated siRNAs and cultured with (þ ) or without ( ) CIT stimulation. (d) Frequency of Igh/c-Myc chromosomal
translocations derived from the indicated samples. (e) Conﬁrmation of SMARCA4 or TOP1 KD in CH12F3-2A cells expressing Tet-inducible microRNA
targeting Top1 mRNA (miR-TOP1). SMARCA4 or TOP1 were KD either by the transfection of the CH12F3-2A cells by SMARCA4 siRNA or by the treatment
with tetracycline (50 nM), respectively. The (þ ) or ( ) signs indicate the presence or absence of Tet-inducible miR-TOP1. Expression of tubulin is shown
as loading control. Genomic DNAs isolated from these cells were used for the translocation assays shown in f and g. (f) Southern blot analysis of
PCR-ampliﬁed fragments with Myc-speciﬁc probe. (g) Frequency of Igh/c-Myc chromosomal translocations derived from the SMARCA4- and/or
TOP1-depleted CH12F3-2A cells. The numbers at bottom-right corners of the blots indicate the number of the translocations detected in total number of
PCR reactions. Statistical signiﬁcance as evaluated by Fisher’s exact tests for indicated sets of data is shown. The position of molecular weight markers is
shown on the left of each western blot image. CIT, CD40L-IL4-TGFb; NS, not signiﬁcant.
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transcription-dependent genomic damage is less frequent than
those induced by DNA damage-inducing drugs. However, it is
noteworthy that SMARCA4 KD almost doubled the percentage of
cells with high level of gH2AX (Supplementary Fig. 8d).
ATPase activity of SMARCA4 is essential for TOP1 recruitment.
To conﬁrm the requirement of ATPase activity of SMARCA4 in
TOP1 recruitment, we analysed the effect of two SMARCA4 point
mutants: K785R (KR) and T910M (TM), both of which are
incorporated normally into the BAF complex, but whose ATPase
activity is highly compromised (Fig. 8a)49. First, we performed
the CSR complementation assay by introducing siRNA-resistant
GFP-tagged human wild-type (WT) or mutated SMARCA4 into
CH12F3-2A cells, along with SMARCA4 siRNAs to deplete
endogenous SMARCA4 (Fig. 8b). SMARCA4-targeted siRNA
treatment decreased the expression of the endogenous
SMARCA4, but not of the exogenous GFP-tagged SMARCA4
(Fig. 8c). CSR was rescued in cells expressing WT SMARCA4, but
not in cells expressing the KR or TM mutant (Fig. 8b–d).
Similarly, using TOP1-ChIP, we found that the defective TOP1
loading at the Igh locus in SMARCA4-depleted cells was
signiﬁcantly restored by expressing the siRNA-resistant WT
SMARCA4, but not the KR or TM mutant (Fig. 8e). These results
showed that the ATPase activity SMARCA4 is required for
efﬁcient CSR as well as for the recruitment of TOP1 to the
Igh locus.
To know whether ATPase activity of SMARCA4 is also
required for TOP1 recruitment to other loci, we performed
TOP1-ChIP upon SMARCA4 depletion in CH12F3-2A cells
pretreated by camptothecin (CPT), and found that SMARCA4
KD reduces the amount of TOP1 bound to chromatin at variety
of tested loci even in the presence of CPT (Figs 7b and 8f). In
addition, we also found that WT but not ATPase dead SMARCA4
proteins could rescue the defect in TOP1 recruitment in the
presence of CPT (Fig. 8f). Taken together, these data suggest that
SMRACA4 ATPase activity is required for TOP1 trapping both in
the absence (Fig. 8e) and presence of CPT (Figs 7b and 8f).
FACT is required for the association of TOP1 with H3K4me3.
To examine the role of another TOP1-binding protein,
H3K4me3, in TOP1 recruitment, we performed peptide pull-
down assays by incubating nuclear extracts of CH12F3-2A cells,
which were prepared under native-IP conditions, with
biotinylated histone H3 tail peptides carrying H3K4me3 or other
histone PTMs. Peptide-bound proteins were collected by
streptavidin beads and subjected to western blotting (Fig. 9a). The
results showed the preferential binding of TOP1 to H3K4me3
peptides, as compared with unmodiﬁed H3, H3K9me3 or
H3K27me3 peptides (Fig. 9a,b). Notably, each of the FACT
subunits (SSRP1 and SPT16) showed relatively strong binding to
H3K4me3 compared with the other peptides, indicating that
TOP1, FACT and H3K4me3 are likely to form a complex
(Fig. 9a,b). In contrast, SMARCA4 showed stronger binding to
H3K9me3 than H3K4me3. To conﬁrm the biological activity of
the biotinylated histone peptides, the bound fractions were also
tested for the presence of known histone-PTM readers, and
shown to contain PHF8, HP1a and SUZ12 in the complexes
bound to H3K4me3, H3K9me3 or H3K27me3, respectively50.
To further ascertain whether FACT is involved in binding of
TOP1 to H3K4me3, we performed TOP1-IP from P388/CPT45-
GFP-TOP1 cells following siRNA-mediated depletion of SSRP1
or SMARCA4, and evaluated the association of TOP1 with
H3K4me3 (Fig. 9c). As previously reported51, both SSRP1 and
SPT16 proteins were signiﬁcantly depleted by the transfection of
siRNA targeting SSRP1 alone (Fig. 9c). Notably, TOP1-IP from
FACT-depleted cells failed to pull down H3K4me3, conﬁrming
that FACT is indeed essential for the binding of TOP1 to
H3K4me3 (Fig. 9c). However, despite the absence of FACT,
interaction of TOP1 with histone H3 and H3.3 remained intact,


























































































Figure 5 | FACT is essential for AID-induced genomic instability even in the TOP1-deﬁcient cells. (a) Schematic illustration of experimental design
for the analysis of DNA double-strand breaks by ligation mediated PCR (LM-PCR) and Igh/c-Myc chromosomal translocations in CH12F3-2A cells.
(b–d) Southern blot analysis of PCR-ampliﬁed fragments with Myc-speciﬁc probe using genomic DNA prepared from CH12F3-2A cells transfected with the
indicated siRNAs. The numbers at bottom-right corners of the blots indicate the number of the translocations detected in total number of PCR reactions.
(e) Frequency of Igh/c-Myc chromosomal translocations derived from the indicated samples. The value of translocation frequency upon TOP1-KD is taken
from Fig. 4c. (f) LM-PCR analysis of the AID-induced DNA double-strand breaks in the Sm region of CH12F3-2A cells following transfection with the
indicated siRNAs. Wedges indicate a threefold increase in DNA amount. (g) Conﬁrmation of single or simultaneous KD of SSRP1 and TOP1 in CH12F3-2A
cells. Expression of tubulin is shown as loading control. Genomic DNAs isolated from these cells were used for the translocation assays and LM-PCR
analysis. Statistical signiﬁcance as evaluated by Fisher’s exact test is shown. CIT, CD40L-IL4-TGFb.
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forms of chromatin also exist. In contrast to the effects of FACT
KD, SMARCA4 KD did not affect TOP1 binding to H3K4me3
or FACT. However, in the absence of FACT, the amount of
SMARCA4 associated with TOP1 was decreased, suggesting that
FACT may be involved in stabilizing the TOP1–SMARCA4
complex. We then analysed the ability of TOP1 to directly bind
H3K4me3 using puriﬁed recombinant human TOP1 protein and
customized histone tail peptide arrays. We found that TOP1 did
not bind H3K4me3 directly, but showed a weak afﬁnity for
N-terminal acetylated histone H3 and H4 peptides, conﬁrming
that binding of TOP1 to H3K4me3 was indirect (Supplementary
Fig. 9).
Next, we performed TOP1-ChIPs to assess the effect of FACT
KD on the recruitment TOP1 to the Igh locus in CH12F3-2A
cells. In contrast to the drastic effect of SMARCA4 KD, FACT KD
did not signiﬁcantly affect TOP1 recruitment to the Igh locus
(Fig. 9d). These results suggest that only a small fraction of the
total TOP1 is associated with FACT and H3K4me3 at the Igh
locus, although the majority of TOP1 is recruited by SMARCA4.
Indeed, the interaction of TOP1 with Histone H3 and H3.3
remained intact even in the absence of FACT (Fig. 9c). Consistent
with these ﬁndings, FACT KD did not cause any signiﬁcant
change in the accumulation of negative superhelicity (Fig. 9e).
To the contrary, FACT appears to accumulate at non-B DNA
containing chromatin as indicated by the increased chromatin
binding of FACT upon TOP1 depletion (Fig. 9f). As FACT KD
caused severe defects in AID-induced DNA breaks, it is likely that
FACT recruits TOP1 to form the TOP1–FACT complex at non-B
DNA containing chromatin, resulting in the irreversible
DNA cleavage at non-B DNA (Fig. 9g). In fact, SSRP1 was
originally identiﬁed as a protein recognizing a speciﬁc structure of
DNA52,53.
Discussion
Mutations or changes in the expression of SMARCA4 or other
BAF complex subunits are associated with a wide variety of
cancers, including lymphoid malignancies. Recent cancer genome
sequencing studies showed that B20% of human cancers
harbour mutations in at least one subunit of the BAF complex,
suggesting a role of the SMARCA4-containing BAF complexes
in the suppression of genomic instability34,35. However, the
mechanisms linking the inactivation of BAF complex subunits
with the induction of genomic instability are not well understood.
A recent study suggested that SMARCA4 is required for
Topoisomerase-2a-mediated decatenation of the newly replicated
sister chromatids during cell division49. On the other hand, the
present study revealed the role of SMARCA4 in the efﬁcient
recruitment of TOP1 during transcription, and showed that
SMARCA4 depletion mimics TOP1 deﬁciency in AID-induced
genomic instability. Since TOP1 deﬁciency as well as defects in
the processing of TOP1-DNA lesions are widely implicated in
transcription-associated genomic instability and neurodegenerative
diseases3–5,16,18, it is possible that the genomic instability induced
by SMARCA4 inactivation in human cancers is due, at least in
part, to the compromised TOP1 recruitment to chromatin.
Recurrent chromosomal translocations involving Ig loci and
proto-oncogenes such as c-MYC, BCL-2, BCL-6 and FGFR are
hallmarks of B-cell malignancies, and are associated with Burkitt’s
lymphoma, follicular lymphoma, diffuse large cell lymphoma and
multiple myeloma, respectively54–56. We observed a dramatic
increase in the frequency of chromosomal translocations
involving Igh and c-Myc loci in SMARCA4 or TOP1-deﬁcient
cells, indicating that defects in the efﬁcient recruitment of TOP1
in SMARCA4-depleted cells induce genomic instability. Notably,
even in the absence of AID activation, a low frequency of
chromosomal translocations was observed in SMARCA4- or
TOP1-depleted CH12F3-2A cells. In addition, SMARCA4
depletion also reduces the TOP1 occupancy and enhances
negative supercoiling at non-Igh AID target loci. However,
it remains to be studied whether depletion of SMARCA4 or
TOP1 enhances mutations or chromosomal translocations
involving these loci.
Although FACT and H3K4me3 also formed a complex with
TOP1, their functions were distinct from that of SMARCA4. We
found that in the absence of FACT, TOP1 failed to associate with
H3K4me3, indicating that TOP1 association with the H3K4me3-
associated protein complex was FACT-dependent (Fig. 9c).
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Figure 6 | SMARCA4 is required for efﬁcient TOP1 recruitment to
chromatin. (a) Schematic diagram showing the position of the ChIP assay
PCR products in Igh locus. Bottom view shows the TOP1-ChIP assay
following SMARCA4 KD in CH12F3-2A cells. Before lysis, the cells were
pretreated with 50 nM of bortezomib for 3 h. ChIP data are normalized as
in Fig. 3h, and represents the mean of the four independent experiments
with standard deviations. (b,c) Analysis of negative superhelicity in
P388/CPT45 cells expressing GFP or GFP-TOP1 (b), and CH12F3-2A cells
after SMARCA4 KD (c). ChIP data is shown as the fraction of
immunoprecipitated DNA (%IP) normalized to the input DNA signals, and
the maximum value in each data set was set as 100%. The data represent
the mean of the three independent experiments with standard deviations.
The mock data show background values from control IP with no antibody.
Asterisks (* and **) denote statistically signiﬁcant differences with Pr0.05
and Pr0.01, respectively, as determined by Student’s t-test. B2m,
beta-2-microglobulin; b-TMP, biotin-trimethylpsoralen.
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abolished the generation of AID-induced S region breaks
as well as Igh/c-Myc translocations. The strong inhibition of
AID-induced breaks by FACT KD was probably due to the defect
of TOP1 association with the H3K4me3–FACT complex, which
may be involved in determining cleavage sites. Although FACT
depletion disturbed the association of TOP1 with H3K4me3,
it did not affect the binding of TOP1 with chromatin through H3
or H3.3. Thus, it is likely that FACT binds to only a small fraction
of SMARCA4-recruited TOP1 to form complex with H3K4me3
probably at non-B DNA. Indeed, the depletion of TOP1, which
induces the formation of non-B DNAs, resulted in the increased
chromatin binding of FACT, indicating that FACT has an afﬁnity
for non-B DNAs (Fig. 9f). In fact, SSRP1, a subunit of FACT, was
originally identiﬁed as a protein recognizing a speciﬁc DNA
structure52,53. In contrast, SMARCA4 depletion suppressed the
recruitment of TOP1 to chromatin, but had little effect on the
association TOP1 with FACT and H3K4me3. Thus, our ﬁndings
showed that SMARCA4 is involved in the general recruitment of
TOP1 to chromatin, while a limited amount of TOP1 recruited by
SMARCA4 is sufﬁcient to promote DNA cleavage through the
interaction with FACT accumulated at the non-B DNA (Fig. 9f,g;
Supplementary Table 7).
High transcriptional levels are associated with mutations,

























































































































































































































































































































Figure 7 | SMARCA4 is required for TOP1 recruitment and maintenance of negative superhelicity at non-Igh targets of AID. (a) Expressions of non-Igh
AID targets, Aicda, and AID non-targeted genes derived from microarray analysis of CIT stimulated CH12F3-2A cells. (b) Top: schematic diagram showing
the position of the ChIP assay PCR products (underlined bar) in the respective Igh, non-Igh and AID non-targeted genes. Bottom: analysis of TOP1-ChIP
(left) and negative superhelicity (right) following SMARCA4 KD in CH12F3-2AA cells. For TOP1-ChIP assay, before lysis, the cells were pretreated with
10mM of camptothecin for 30min. ChIP data are normalized as in Fig. 3h, and represent the mean of the three independent experiments with standard
deviations. Asterisks (* and **) denote statistically signiﬁcant differences with Pr0.05 and Pr0.01, respectively, as determined by Student’s t-test.
B2m, beta-2-microglobulin; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; ND, not detected; NS, not signiﬁcant; Tcrd, T-cell receptor delta chain.
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can threaten genomic stability5,57. TOP1 and transcription-
induced non-B DNA structures formed at repetitive or
palindromic sequences are involved in transcription-associated
mutagenesis, unstable triplet repeat diseases and AID-induced
Ig gene diversiﬁcation11–13,23,24. In addition, there is evidence
that FACT and H3K4me3 are involved in AID-induced genetic
alterations25,29,30. Here, we showed that KD of TOP1 or
SMARCA4 increased the accumulation of negative supercoils,
and promoted V and S region DNA cleavage, resulting in
increased frequencies of SHM and Igh/c-Myc chromosomal
translocations. Notably, the simultaneous depletion of
SMARCA4 and TOP1 did not show additive effects on SHM or
Igh/c-Myc translocations, suggesting that the functions of these
two factors may overlap. Taken together, these results suggest that
the SMARCA4 KD-mediated augmentation of SHM or Igh/c-Myc
translocations was due to inefﬁcient TOP1 recruitment to the S
and Myc regions. In addition, we showed that the ATPase activity
of SMARCA4, which is essential for chromatin remodelling,
was required for efﬁcient TOP1 recruitment.
The accumulation of unwound DNA in SMARCA4- or
TOP1-depleted cells increased the frequency of Igh/c-Myc
translocations, even in the absence of AID induction, suggesting
that the excessive accumulation of non-B DNA promotes DNA
cleavage. On the other hand, the depletion of FACT, which was
required for H3K4me3 marking and for the association of TOP1
with H3K4me3 did not affect the accumulation of non-B DNA,
but completely abolished the AID-induced DNA cleavage and
Igh/c-Myc translocations. Notably, TOP1 KD, which normally
results in the accumulation of non-B DNA structures, failed
to induce Igh/c-Myc translocations in FACT-depleted cells
(Fig. 5a–g). These data suggest that the accumulation of non-B
DNA structures promotes AID-induced DNA cleavage only in
the presence of FACT. Taken together, these observations
suggest that AID-induced genetic alterations and transcription-
dependent genomic instability share a common mechanism
involving the accumulation of non-B DNA and the recruitment
of TOP1 to chromatin, which is mediated by SMARCA4, FACT
and H3K4me3.
In conclusion, we showed that TOP1 is recruited by
SMARCA4 to chromatin so that transcription-associated uneven
distribution of superhelix is corrected. A small fraction of TOP1
binds to FACT that is enriched at non-B DNA containing
chromatin, and forms a complex with H3K4me3, which is



































































































Figure 8 | ATPase activity of SMARCA4 is essential for efﬁcient TOP1 recruitment. (a) Top: schematic representation of the human SMARCA4 protein
showing the positions of the mutations in the analysed mutants. Bottom: schematic representation of GFP-fused WT- or mutated-SMARCA4 proteins.
(b) Schematic representation of the experimental design for the CSR complementation and TOP1-ChIP assays. (c) Conﬁrmation of the siRNA-mediated KD
of endogenous mouse SMARCA4, and expression of GFP-tagged human SMARCA4 (WT, and KR and TM mutants). Expression of b-actin is shown as
loading control. (d) CSR complementation assay using CH12F3-2A cells expressing siRNA-resistant human SMARCA4. Data are presented as % IgA
switching relative to the IgA switching in cells transfected with control siRNA (siCONT) with similar GC content. The data represent the mean of the three
independent experiments with standard deviations. (e,f) TOP1-ChIP assays following CSR complementation in CH12F3-2A cells. Before lysis, the cells were
pretreated with either 50 nM of bortezomib for 3 h (e) or 10mM of camptothecin for 30min (f). Top view shows schematic diagram with the position of the
ChIP assay PCR products in Igh locus. ChIP data were normalized as in Fig. 3h, and represent the mean of the three independent experiments with standard
deviations. Asterisks (* and **) denote statistically signiﬁcant differences with Pr0.05 and Pr0.01, respectively, as determined by Student’s t-test.
The position of molecular weight markers is shown on the left of each western blot image. B2m, beta-2-microglobulin; CIT, CD40L-IL4-TGFb; CSR,
class switch recombination; Eef1a1, eukaryotic translation elongation factor 1 alpha 1; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; NS, not
signiﬁcant; Tcrd, T-cell receptor delta chain.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10549 ARTICLE
NATURE COMMUNICATIONS | 7:10549 |DOI: 10.1038/ncomms10549 | www.nature.com/naturecommunications 11
FACT dissociates TOP1 from H3K4me3-associated complex,
and abolishes AID-induced DNA cleavage. Deﬁciency of either
TOP1 or SMARCA4 reduces TOP1 binding to chromatin,
and promotes the formation of non-B DNA structures, but a
small amount of TOP1 can still bind to FACT and H3K4me3 at
non-B DNA containing chromatin, and promotes genomic
instability.
Methods
Cell lines and RNAi oligonucleotide transfection. The human Burkitt’s lym-
phoma line BL2, the mouse B-cell lymphoma line CH12F3-2A expressing Bcl2, and
the TOP1-deﬁcient P388/CPT45 cells expressing GFP (P388/CPT45-GFP) or GFP-
tagged human TOP1 (P388/CPT45-GFP-TOP1) were previously described24,29,44.
The BL2 and P388/CPT45 cells also express AIDER, a fusion protein in which AID
is fused to the hormone-binding domain of the estrogen receptor (ER), which
is activated by treating cells with OHT. Chemically modiﬁed Stealth siRNA



















































































































































































































































ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10549
12 NATURE COMMUNICATIONS | 7:10549 | DOI: 10.1038/ncomms10549 | www.nature.com/naturecommunications
oligonucleotides (Invitrogen) were introduced into cells using the Nucleofector
96-well electroporation system (Lonza) to knockdown the expression of speciﬁc
genes. After electroporation, the cells were cultured for 24 h, and then stimulated
by CIT (CD40L, IL4 and TGFb) or OHT (1 mM), and cultured for another 24–72 h
before collection and analysis. The list of antibodies, primers and Stealth siRNAs
used in this study is shown in Supplementary Tables 8–10.
Analysis of CSR and SHM. CH12F3-2A cells were CIT-stimulated for 24–48 h to
induce CSR, and surface expression of IgM and IgA was analysed by staining with
FITC-conjugated anti-mouse IgM (eBioscience) and PE-conjugated anti-mouse
IgA (Southern Biotechnology Associates) antibodies, respectively. Flow cytometry
analysis were performed using a Becton-Dickinson FACS-Calibur, as previously
described30. Analysis of CSR in NIH 3T3 cells expressing artiﬁcial switch substrate
SCI (m, a) and AIDER was performed as described earlier42. Brieﬂy, NIH 3T3 cells
were transfected with control siRNA or human SMARCA4 siRNA using
Lipofectamine 2000 (Invitrogen). Twenty-four hours post transfection, cells
were stimulated with 1 mM of OHT for 48 h, and stained with allophyco-cyanin-
conjugated anti-CD8a (eBioscience).
To analyse the effect of SMARCA4 depletion on SHM in BL2 cells expressing
AIDER, the cells were transfected with SMARCA4 siRNA, cultured for 24 h and
then treated with OHT (1mM) for 72 h, followed by total RNA extraction using
TRIzol (Invitrogen). The cDNA was synthesized from 0.5–1 mg of total RNA using
Oligo d(T)-primers and SuperScript III (Invitrogen). PCR fragments corresponding
to the 426-bp rearranged VH4–39-JH5 region were cloned into the pGEM-T Easy
Vector (Promega). The 408-bp sequence between the two primers was analysed for
the presence of mutations58. Analysis of somatic mutations in the S-region of the
P388/CPT45 cells was performed as previously described24. The mutation
frequency was calculated as the number of mutations per total bases from
independent experiments. The primers used for SHM analysis are shown in
Supplementary Table 8.
Co-immunoprecipitation. TOP1-deﬁcient mouse B-cell lymphoma cell line
P388/CPT45 expressing AIDER, and either GFP or GFP-TOP1 was used to co-IP
TOP1-associated proteins. Chemical crosslinking-based IP (DSP-IP) was
performed using DSP (Thermo Scientiﬁc)59. Cells (2 108) were incubated in
phosphate-buffered saline (PBS) containing 0.6mM DSP for 30min at 4 C
with mild rotation. After removing PBS, the remaining DSP was quenched by
incubating the cells in TBS (50mM Tris-Cl pH 7.4, 150mM NaCl, 1mM EDTA)
for 15min on ice. To prepare nuclear extracts, cells were subjected to hypotonic
lysis, and then the isolated nuclei were lysed in lysis buffer (50mM Tris-Cl pH 7.5,
150mM NaCl, 0.25% Triton X-100, 0.25% Na-deoxycholate, 0.05% SDS, 1mM
EDTA, 5% glycerol) containing 5mM MgCl2, 500Uml 1 of Benzonase nuclease
(Novagen), 300mM NaCl, and protease inhibitor cocktail (Roche). The nuclear
extract was then sonicated for 10min, followed by rotation for 1 h at 4 C and
centrifugation at 20,000g for 10min. The supernatant was pre-cleared with blocked
agarose beads (Chromotek) and then incubated with GFP-Trap_A (Chromotek)
for 2 h at 4 C. The agarose beads were washed sequentially with TBS, lysis
buffer, high-salt lysis buffer (500mM NaCl) and TBS. Finally, the beads were
re-suspended in 100ml 2 SDS-sample buffer containing 5% b-mercaptoethanol,
and heated for 10min at 95 C to elute the bound proteins.
To perform IP without crosslinking (native-IP), the nuclei prepared from
2 108 cells were suspended in HGN165 buffer (20mM HEPES pH 7.4, 10%
glycerol, 165mM NaCl) containing 2mM MgCl2, 1mM DTT, 500Uml 1 of
Benzonase nuclease, 0.1% Triton X-100 and protease inhibitor cocktail, followed by
mild sonication to rupture the nuclei and rotation at 4 C for 1 h. After collecting
the supernatant, the insoluble pellet was sequentially extracted with the above-
mentioned buffer containing a higher concentration of Triton X-100 (0.3%),
followed by extraction with buffer containing a higher concentration of NaCl
(200 and 250mM). The four extracts were pooled, centrifuged and the
supernatants were IPed using GFP-Trap_A. The beads were washed extensively
with HGN165 buffer, and the bound fractions were eluted as described above.
To perform reverse co-IP, HEK 293T cells were transfected with 10 mg of
pEGFP-C2-SSRP1 or pEGFP-C2-SMARCA4 plasmids, and 48 h post transfection,
the cells were collected and nuclear extracts were IPed as described for native-IP.
The eluted proteins were subjected to western blotting with speciﬁc antibodies.
Less-cropped western blots are shown in Supplementary Fig. 10.
Proteomic analysis. For quantitative analysis of crosslinked IP samples, 18O post-
labelling method was used60. Brieﬂy, 130mg samples obtained from the crosslinked
IP experiments were digested with 1:50 modiﬁed porcine trypsin (Promega) in the
presence of 8M urea and 100mM Tris-HCl (pH 8.0) after reduction with 2mM
dithiothreitol and alkylation with 10mM iodoacetamide. The reaction was stopped
with 1% TFA, and cleaned using a C18 cartridge (Bond Elute C18 EWP, Agilent).
The eluted peptides were divided and dried completely in a Speed-Vac
concentrator (Thermo Fisher). One half of the dried peptides were labelled with
18O and the rest with 16O by incubating with 1:50 trypsin/peptide (w/w) in 100ml
of 50mM NH4HCO3 buffer made either in H218O or in H216O containing 10mM
CaCl2. After incubating for 5 h at 37 C with shaking, the reaction was stopped by
boiling the sample in a 100 C water bath for 20min, followed by immediate
freezing at  80 C. Equal amounts of TOP1 and control IP samples were mixed
and fractionated over a strong cation exchange column61. To compensate for the
incomplete labelling, TOP1 sample was labelled with 18O and control sample was
labelled with 16O in one sample set, while the labelling was reversed in the second
set. Twenty-two fractions obtained were separately subjected to the LC-MS/MS
(liquid chromatography tandem mass spectrometry) analysis, using nano
high-performance liquid chromatography (LC Packings, UltiMate 3000) interfaced
online to a hybrid Fourier-transform ion cyclotron resonance mass spectrometer
(Thermo Fisher, LTQ-FT). The details of the analytical conditions were as
described previously62. The data were processed using a Mascot Distiller software
(ver. 2.3.2, Matrix Science, UK), and subjected to database search (Mascot, version
2.3, Matrix Science) against Mus musculus protein sequences in the Swiss-Prot
database. Mascot distiller was also used for the quantiﬁcation of proteins.
Owing to the limited amounts of samples obtained, semi-quantitative analysis
was used for native-IP experiments. Brieﬂy, 30 mg of immunoprecipitated protein
samples were electrophoresed on SDS–PAGE gels (4–20% acrylamide gel), and the
gel was stained with Coomassie brilliant blue. Each lane was cut into 15 slices of
equal size, destained and subjected to in-gel digestion with trypsin as described
previously63. The obtained peptides were subjected to LC-MS/MS analyses as
described above.
Histone peptide pull-down assay. The nuclear extracts for histone peptide
pull-down (PPD) assays were prepared as described for native-IP. For PPD assay,
40 ml of streptavidin Dynabeads M-280 (Invitrogen) were coupled to 20 mg of
biotinylated histone peptides and then incubated with a nuclear extract equivalent
to 2 107 cells for 2 h at 4 C. The magnetic beads were washed extensively with
HGN165 buffer, and peptide-bound proteins were eluted by heating the beads in
100 ml of 2 SDS-sample buffer containing 5% b-mercaptoethanol at 95 C for
10min. The eluted proteins were subjected to western blotting with speciﬁc
antibodies. Information about the peptides used for PPD assay is shown in
Supplementary Table 11.
Analysis of Igh/c-Myc chromosomal translocations. The Igh/c-Myc transloca-
tion junctions (derivative chromosome 15) were PCR-ampliﬁed from genomic
Figure 9 | FACT is required for TOP1-H3K4me3 complex formation. (a) Histone peptide pull-down assays using biotinylated peptides carrying either
H3K4me3 or other histone PTMs. Cell lysates for peptide pull-down assays from CIT-stimulated CH12F3-2A cells were prepared as described for native-IP
(see ‘Methods’). Pulled-down proteins were immunoblotted with the indicated antibodies. (b) Densitometric quantiﬁcation of western blot images shown
in Fig. 9a is performed to analyse relative binding of the indicated proteins with the histone peptides. (c) TOP1 co-IP following SSRP1 or SMARCA4 KD in
P388/CPT45-GFP-TOP1 cells. Cell lysates prepared form P388/CPT45-GFP-TOP1 cells transfected with the indicated siRNAs were subjected to
immunoprecipitation with GFP-Trap_A, and the IPed proteins were western blotted with the indicated antibodies. (d) TOP1-ChIP analysis following SSRP1
KD in CH12F3-2A cells. Before lysis, the cells were pretreated with 50 nM of bortezomib for 3 h. ChIP data were normalized as in Fig. 3h. The data represent
the mean of the three independent experiments with standard deviations. The mock data show background values from control IP with no antibody. (e)
Analysis of negative superhelicity in the SSRP1-depleted cells. ChIP data were normalized as in Fig. 6c. (f) Analysis of SSRP1-ChIP following TOP1 KD in
CH12F3-2A cells. ChIP data are normalized as in Fig. 3h, and represent the mean of the three independent experiments with standard deviations. Asterisks
(*) denote statistically signiﬁcant differences with Pr0.05, as determined by Student’s t-test. The position of molecular weight markers is shown on the
left of each western blot image. B2m: beta-2-microglobulin; b-TMP, biotin-trimethylpsoralen. (g) Diagrammatic representation of role of SMARCA4, FACT
and H3K4me3 in TOP1-mediated genomic instability. High levels of transcription lead to the accumulation of negative superhelix. SMARCA4 recruits TOP1
to actively transcribed chromatin to correct excessive accumulation of negative superhelix and prevent the formation of non-B DNAs at repetitive
sequences. Reduction in TOP1 recruitment causes accumulation of negative superhelix leading to the formation of non-B DNA structures at repetitive
sequences. On the other hand, FACT binds to non-B DNA through SSRP1, and traps a fraction of SMARCA4-recruited TOP1, which facilitates the formation
of a complex of TOP1, FACT and H3K4me3 at non-B DNA containing chromatin, resulting in the DNA cleavage.
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DNA obtained from 48 h CIT-stimulated CH12F3-2A cells using the Expand Long
Template PCR System64. A total of 16 to 48 aliquots of genomic DNA were
analysed in separate reactions. The conditions for both ﬁrst and second round of
PCR were as follows: 94 C for 3min, followed by 25 cycles at 94 C for 15 s; 62 C
for 15 s; 68 C for 7.5min and a ﬁnal extension of 5min at 68 C. The PCR
products were electrophoresed on ethidium bromide-containing 1% agarose gels
and subjected to Southern blotting with Myc-speciﬁc probe. The primer and probe
sequences are shown in Supplementary Table 8.
Analysis of DNA double-strand breaks. Genomic DNAs were prepared
from CH12F3-2A cells stimulated with CIT for 24 h. DSBs were analysed by
ligation-mediated PCR as previously described65,66. Brieﬂy, living CH12F3-2A
cells were isolated by Percoll density gradient centrifugation and embedded in
low-melting-point agarose followed by DNA extraction within low-melting agarose
plugs. A total of 20 ml of genomic DNA was ligated with linker in a ﬁnal volume of
100ml. Ligation reaction was stopped by adding 200 ml of H2O followed by heating
at 70 C for 10min. Threefold dilutions of input DNA were PCR ampliﬁed by
KOD-FX-Neo polymerase (TOYOBO). The amount of ligated DNA in the input
was normalized with Gapdh DNA. PCR products were electrophoresed on 1%
agarose gels followed by Southern blotting with 50 Sm probe. The primer and probe
sequences are shown in Supplementary Table 8.
Chromatin immunoprecipitation. The gH2AX-ChIP assay was performed using
ChIP-IT Express Kit (Active Motif) as previously described29. For TOP1-ChIP,
CIT-stimulated CH12F3-2A cells (3 106) were treated with either 50 nM of
Bortezomib (Janssen Pharmaceuticals) for 3 h or 10 mM of camptothecin
(Calbiochem) for 30min. The cells were rapidly lysed in 0.9ml of 10mM Tris-Cl
pH6.8, 20mM EDTA, 4% Triton X-100, 6M guanidinium isothiocyanate, 1%
Sarkosyl and 60mM DTT. The genomic DNA was precipitated by addition of
0.6ml of 100% ethanol followed by centrifugation67. The genomic DNA was
sheared using components ChIP-IT Express Kit (Active Motif), and 20 mg of
genomic DNA was immunoprecipitated with 3 mg of TOP1 antibody and Protein
G-coupled magnetic beads (Active Motif). The beads were sequentially washed by a
standard series of wash buffers (low salt, high salt, LiCl and Tris/EDTA), and the
IPed chromatin was eluted with 1% SDS and 0.1M NaHCO3 and puriﬁed using
phenol–chloroform. The locus-speciﬁc enrichment was detected by qPCR, and
normalized to the input DNA. The primers and antibodies used are shown in
Supplementary Tables 8 and 9, respectively.
Analysis of negative superhelicity. To identify regions of negative
superhelicity, we partially adapted a biotin-trimethylpsoralen (bTMP)-based
assay described elsewhere68. Biotin-TMP was synthesized by the biotinylation of
40-aminomethyltrioxsalen (Sigma). Brieﬂy, cells were treated with 30 mgml 1
bTMP for 20min in the dark and then ultraviolet crosslinked at 360 nm for 10min.
Genomic DNA was isolated using SDS and proteinase K digestion followed by
phenol–chloroform extraction. Ultraviolet-dependent bTMP crosslinking of
genomic DNA was conﬁrmed by dot blot using HRP-conjugated streptavidin as a
probe. For ChIP analysis, the sheared DNA was IPed with streptavidin Dynabeads
M-280 (Invitrogen). The beads were washed as described above and the IPed DNA
was eluted by boiling the beads in 95% formamide containing 10mM EDTA for
10min at 90 C. The eluted fractions were pooled and puriﬁed using the Qiagen
PCR puriﬁcation kit. The locus-speciﬁc enrichment was detected by qPCR
normalized to the input DNA. A list of the primers used is shown in
Supplementary Table 8.
Analysis of cell proliferation. The effect of SMARCA4 depletion on CH12F3-2A
cell proliferation was analysed using CellTrace CFSE Cell Proliferation Kit
(Molecular Probes)69. Brieﬂy, CH12F3-2A cells were transfected with siSMARCA4
or control siRNA (siCONT), and immediately labelled with 5 mM of CFSE
(carboxyﬂuorescein diacetate succinimidyl ester) for 15min at 37 C. CIT was
added 24 h later and FACS analysis was performed at 24 h post stimulation
on a Becton-Dickinson FACS-Calibur ﬂow cytometer. The cells treated with
Aphidicolin (2 mgml 1), a well-known inhibitor of cell cycle progression,
were used as a positive control.
Flow cytometry analysis of cH2AX phosphorylation. FACS-based H2AX
phosphorylation assay kit (Millipore, catalogue # 17–344) was used to stain gH2AX
in CH12F3-2A cells, essentially as described by the manufacturer. The cells were
analysed on a Becton-Dickinson FACS-Calibur ﬂow cytometer.
Construction of plasmids. The human SMARCA4 cDNA was PCR ampliﬁed
using the pCMV5-BRG1-FLAG plasmid (Addgene#17873) as a template, and
cloned into the SalI/SmaI sites of the pEGFP-C2 vector. Constructs expressing
mutant SMARCA4 (K785R or T910M) with defective ATPase activity were
prepared by amplifying the WT construct using the indicated mutagenesis primers
(Supplementary Table 8). Plasmid for the expression of GFP-SSRP1 was previously
described29. These constructs were used for CSR rescue experiments (see below)
and reverse co-IPs in HEK 293T cells.
CSR complementation assay. To evaluate the requirement for ATPase activity of
SMARCA4 in CSR, 2mg of the siRNA-resistant-WT or -mutant SMARCA4
expression plasmids (described above) were co-transfected along with SMARCA4
siRNA oligonucleotides into CH12F3-2A cells. The cells were cultured for 24 h and
then treated with CIT for 24–48 h. CSR complementation was analysed as
described previously29.
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